Showing results (141-150 of 383) with videos related to
Sort By:
Pageof 39
Journal of Palliative Medicine|May 14, 2005
Palliative care needs of cancer patients in U.S. nursing homesVanessa M P Johnson, Joan M Teno, Meg Bourbonniere, et al.Obstetrics and Gynecology Clinics of North America|December 1, 1990
Preconceptional planningT B Jones, M P Johnson, A Drugan, et al.Fetal Diagnosis and Therapy|May 1, 1993
Age of gestation (size) at embryonic demise: tailoring counseling for lethal versus potentially viable aneuploidyA Drugan, M P Johnson, N B Isada, et al.Mechanisms of Ageing and Development|July 1, 1990
Enhancement of anti-influenza cytotoxic T-lymphocyte activity in senescent mice by vaccination early in lifeB S Bender, E Tallman, M P Johnson, et al.Obstetrics and Gynecology Clinics of North America|March 1, 1997
Gene therapy. Is the future here yet?Y Yaron, R L Kramer, M P Johnson, et al.Molecular Pharmacology|February 1, 1994
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptaminesM P Johnson, R J Loncharich, M Baez, et al.Fetal Diagnosis and Therapy|March 23, 1999
Ontogeny of clenched-hand development in trisomy 18 fetuses: A serial transabdominal fetoscopic observationR A Quintero, M P Johnson, G Mendoza, et al.Current Opinion in Obstetrics & Gynecology|October 1, 1994
Biochemical screeningM I Evans, J E O'Brien, E Dvorin, et al.Biochimica Et Biophysica Acta|May 24, 1995
Species differences in 5-HT2A receptors: cloned pig and rhesus monkey 5-HT2A receptors reveal conserved transmembrane homology to the human rather than rat sequenceM P Johnson, M Baez, J D Kursar, et al.Fetal Therapy|January 1, 1989
Genetic correction of hereditary diseaseM P Johnson, A Drugan, O J Miller, et al.Pageof 39